Moreover, serum FSCN1 levels were significantly higher in ACC patients compared with obese/T2D patients, who have higher levels of FSCN1, probably due to kidney overload/damage associated to diabetes, as already demonstrated in renal injury associated with renal transplantation (15). The gene discussed is FSCN1; the disease is adrenal cortex carcinoma.